-
BofA Says GlaxoSmithKline's Decision To Halt Feladilimab Studies Is Disappointing
Thursday, April 15, 2021 - 12:15pm | 266Read More...GlaxoSmithKline plc (NYSE: GSK) announced the termination of the Phase II and Phase III studies of feladilimab, its ICOS receptor agonist in head and neck cancer. This comes as a disappointment, as the candidate could potentially address a multimillion-dollar market, according to BofA Securities....
-
What Are The 5 Drivers That Could Affect Walt Disney Stock?
Wednesday, April 14, 2021 - 11:47am | 352Read More...Walt Disney Co (NYSE: DIS) is poised to benefit from an uptick in amusement park attendance in the fiscal second quarter, with initial indicators suggesting robust travel to the state of Florida, according to BofA Securities. The Walt Disney Analyst: Jessica Reif Ehrlich maintained a Buy rating for...
-
BofA Initiates Bullish Coverage Of Harley-Davidson: Here's Why
Wednesday, April 14, 2021 - 10:27am | 299Read More...Harley-Davidson Inc’s (NYSE: HOG) stock is poised to trade at a premium to its historical multiple, given 2021 earnings upside and accelerating brand momentum, according to BofA Securities. The Harley-Davidson Analyst: Robert Ohmes initiated coverage of Harley-Davidson with a Buy rating and a...
-
6 Reasons To Be Bullish On iHeartMedia Stock
Tuesday, April 13, 2021 - 11:11am | 323Read More...IHeartMedia Inc’s (NASDAQ: IHRT) results for the first quarter of 2021 are likely to reflect a significant sequential improvement in advertising trends, healthy savings on modernization and restructuring initiatives and strong digital growth, according to BofA Securities. The iHeartMedia...
-
What Are The Tailwinds For BofA's US Bancorp Upgrade?
Monday, April 12, 2021 - 11:49am | 227Read More...U.S. Bancorp (NYSE: USB) faces the strong potential for upward revisions to 2021 earnings, driven by PPNR (pre-provision net revenue), apart from solid credit leverage, according to BofA Securities. The U.S. Bancorp Analyst: Erika Najarian upgraded the rating for U.S. Bancorp from Underperform to...
-
5 Trends Auto Stock Investors Should Watch In 2021
Monday, April 12, 2021 - 11:31am | 699Read More...Auto stocks have been some of the top performers in the market in the last year as investors position themselves for long-term growth trends from the next generation of auto technology, including electric and autonomous vehicles. BofA Securities analyst John Murphy recently discussed five key...
-
Rev Your Engines: Why BofA Reinstates Ally, Santander At Buy
Monday, April 12, 2021 - 10:57am | 394Read More...While the shares of both Ally Financial Inc (NYSE: ALLY) and Santander Consumer USA Holdings Inc (NYSE: SC) are “at the high end of their respective trading ranges,” auto lenders are expected to face a positive economic and operating environment, which should drive earnings estimates...
-
BofA Remains Bullish On Clover Health With Improving Visibility Into Growth
Friday, April 9, 2021 - 3:27pm | 286Read More...Clover Health Investments Corp (NASDAQ: CLOV) has been chosen by the Centers for Medicare and Medicare Services (CMS) to participate in Direct Contracting (DC) across 10 states. While the news is not surprising, the program’s official launch is positive for the company, according to BofA...
-
BofA Names HubSpot Top Software Stock: Here's Why
Friday, April 9, 2021 - 10:41am | 237Read More...HubSpot Inc (NYSE: HUBS) is a top pick when considering the 4Ms of market, moat, management, and margins, according to BofA Securities. The HubSpot Analyst: Brad Sills initiated coverage of HubSpot with a Buy rating and a price target of $600. The HubSpot Thesis: HubSpot addresses a total...
-
Why BofA Is Bullish On DocuSign Stock
Thursday, April 8, 2021 - 12:37pm | 228Read More...DocuSign Inc (NASDAQ: DOCU) is an industry-leading brand in the contract lifecycle management and eSignature market, and the market is an underappreciated one, according to BofA Securities. The DocuSign Analyst: Brad Sills reinstated coverage of DocuSign with a Buy rating and $250 price target....
-
Why Did BofA Upgrade 3 Triple-net Lease REITs?
Wednesday, April 7, 2021 - 10:32am | 404Read More...The rating changes in the net lease segment reflects a shift in focus from portfolio quality to growth, which is likely to be key to net lease performance in 2021, according to BofA Securities. The REIT Analyst: Joshua Dennerlein upgraded the ratings for EPR Properties (NYSE: EPR), Essential...
-
Solar Analyst Offers 'What If?' Scenarios For Residential Plays After Biden's Infrastructure Plan
Tuesday, April 6, 2021 - 7:30pm | 614Read More...Residential solar power installations are part of the elephantine mix of infrastructure projects and concepts put forth in President Joe Biden's $2-trillion American Jobs Plan. And while residential solar is a fairly minuscule consideration in the plan's energy-focused endeavors, analysts...
-
BofA Downgrades Credit Suisse Again: Archegos Losses 'Double What We Expected'
Tuesday, April 6, 2021 - 11:26am | 505Read More...Credit Suisse Group AG (NYSE: CS) shares traded lower Tuesday morning after the bank announced a $4.7-billion charge tied to the meltdown of U.S. hedge fund Archegos Capital. One Wall Street analyst responded by downgrading Credit Suisse for the second time in just over a week. The Credit...
-
Lululemon's Prospects Remain Fit
Wednesday, March 31, 2021 - 3:05pm | 639Read More...Athletic apparel maker Lululemon Athletica Inc (NASDAQ: LULU) reported fourth-quarter results that came in better than expected but were overshadowed by management's outlook of higher investments in 2021. The Lululemon Analysts: Wells Fargo analyst Ike Boruchow maintains a Hold rating on...
-
Chewy's Q4 Beat Shows Strength In Pet Market, Says Bullish BofA
Wednesday, March 31, 2021 - 12:48pm | 259Read More...Chewy Inc (NYSE: CHWY) beat revenue and earnings estimates for the fourth quarter, backed by continued momentum in pet spending, according to BofA Securities. The Chewy Analyst: Nat Schindler maintained a Buy rating on Chewy with an unchanged $133 price target. The Chewy Takeaways:...
